• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Celldex Therapeutics Inc

+ Add to Watchlist

TCE1:GR

10.360 EUR 0.190 1.80%

As of 09:38:49 ET on 07/11/2014.

Snapshot for Celldex Therapeutics Inc (TCE1)

Open: 10.265 Day's Range: 10.263 - 10.505 Volume: 390
Previous Close: 10.550 52wk Range: 7.887 - 28.288 1-Yr Rtn: -30.70%

Stock Chart for TCE1

No chart data available.
  • TCE1:GR 10.360
  • 1D
  • 1M
  • 1Y
10.550
Interactive TCE1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TCE1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.3390
Est. PEG Ratio -
Market Cap (M EUR) 925.75
Shares Outstanding (M) 89.36
30 Day Average Volume 699
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TCE1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TCE1

Celldex Therapeutics Inc., a biopharmaceutical company, uses applications of immunology to prevent and treat diseases. The Company's products treat autoimmune diseases, cardiovascular diseases, cancer, and inflammation, as well as infectious diseases and organ transplant rejection.

Anthony Salvatore MarucciPresident/CEOAvery W Catlin "Chip"Senior VP/CFO/Secretary
Thomas DavisSenior VP/Chief Medical OfcrTibor KelerSenior VP/Chief Scientific Ofcr
More Company Profile & Key Executives for TCE1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil